For help on how to get the results you want, see our search tips.
2 results
Medicine
Referrals Remove Referrals filter
Referral status
European Commission final decision Remove European Commission final decision filter
Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter
Referral type
Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter
Article 5(11) referrals (prior to January 2010) Remove Article 5(11) referrals (prior to January 2010) filter
Article 31 referrals Remove Article 31 referrals filter
Article 29(4) referrals Remove Article 29(4) referrals filter
Referral authorisation model
Nationally authorised product(s) Remove Nationally authorised product(s) filter
Referral safety status
Yes Remove Yes filter
Referral decision making model
PRAC-CMDh Remove PRAC-CMDh filter
Categories
Human Remove Human filter
-
List item
Referral: Ifosfamide solutions
ifosfamide, associated names: Ifosfamide Eg, Ifo-Cell, Ifo-Cell N, Ifo-Cell N 2000, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2021, EC decision date: 21/06/2021, Last updated: 19/07/2021 -
List item
Referral: Paracetamol modified-release
paracetamol, associated names: Alvedon, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2017, EC decision date: 19/02/2018, Last updated: 01/03/2018